Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash ...
That brings us to Recursion Pharmaceuticals (RXRX 12.76%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results